Endo unit cleared of liability in first testosterone replacement trial

NEW YORK, Nov 16 (Reuters) - A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.